Your search returned 2 results.

Results
	1.	Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. [electronic resource] by Trudel, Suzanne Lendvai, Nikoletta Popat, Rakesh Voorhees, Peter M Reeves, Brandi Libby, Edward N Richardson, Paul G Anderson, Larry D Sutherland, Heather J Yong, Kwee Hoos, Axel Gorczyca, Michele M Lahiri, Soumi He, Zangdong Austin, Daren J Opalinska, Joanna B Cohen, Adam D Producer: 20190617 In: The Lancet. Oncology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial. [electronic resource] by Robak, Tadeusz Warzocha, Krzysztof Govind Babu, K Kulyaba, Yaroslav Kuliczkowski, Kazimierz Abdulkadyrov, Kudrat Loscertales, Javier Kryachok, Iryna Kłoczko, Janusz Rekhtman, Grygoriy Homenda, Wojciech Błoński, Jerzy Z McKeown, Astrid Gorczyca, Michele M Carey, Jodi L Chang, Chai-Ni Lisby, Steen Gupta, Ira V Grosicki, Sebastian Producer: 20180112 In: Leukemia & lymphoma vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search